O
Omrix Biosurgery Israel
Profile managed by Bizz IdOmrix (J&J / Ethicon)
Israel
201-500 employees
2000
Description
Israeli division of J&J/Ethicon (acquired in 2008 for $438M). Develops and manufactures plasma-derived biosurgical products: fibrin sealants (EVICEL®), hemostatic matrices and tissue adhesives. J&J center of excellence for biosurgicals in Israel.